Clinical Trial Update: Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients

View source ↗

Summary

Investigator-initiated, observational multicenter real-world study evaluating the effectiveness and safety of Anifrolumab in active systemic lupus erythematosus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• SAPHNELO (ANIFROLUMAB-FNIA)

Snippet

Sponsor: University of Pisa | Conditions: Systemic Lupus Erythematosus | Status: RECRUITING